Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
41,008,925
-
Shares change
-
-1,858,325
-
Total reported value, excl. options
-
$101,698,321
-
Value change
-
-$4,079,285
-
Number of buys
-
34
-
Number of sells
-
-22
-
Price
-
$2.48
Significant Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q4 2015
72 filings reported holding TRXC - TRANSENTERIX INC - COM NEW as of Q4 2015.
TRANSENTERIX INC - COM NEW (TRXC) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41,008,925 shares
.
Largest 10 shareholders include Aisling Capital LLC (8,335,819 shares), SV Life Sciences Advisers, LLC (7,546,692 shares), MASTERS CAPITAL MANAGEMENT LLC (4,575,984 shares), JPMORGAN CHASE & CO (3,750,000 shares), StepStone Group LP (3,480,512 shares), PERCEPTIVE ADVISORS LLC (1,715,941 shares), SABBY MANAGEMENT, LLC (1,521,505 shares), VANGUARD GROUP INC (1,476,909 shares), BlackRock Fund Advisors (1,154,449 shares), and GOLDMAN SACHS GROUP INC (825,252 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.